双水平无创呼吸机
Your current location : Home >> Product >> The series of High flow humidification transnasal oxygen therapy

NewsNews

ContactContact Us

Shenyang Maisi Medical Technology Co., Ltd

公司总部 : 沈阳市浑南区金辉街10-4号

销售服务热线 : 详情请查看营销中心

售后服务热线:13998309142

Tel : 86-24-31682686

Fax : 86-24-23785299-8008

网址:www.rms-care.com

邮箱:info@rms-care.com

全国免费咨询电话:400-024-8010

HUMID-BH90

2021-05-08 09:33:56
Times
HUMID-BH90
Content:

BHHHHH.png

The HUMID-BH automatically adjusts the oxygen concentration from 21% to 100%, the flow rate from 2 to 90 L/min, the temperature at 31°C -34°C&37°C, and the humidity saturation adjustment in 7 levels.


High flow humidification oxygen therapy (HFNC) is a treatment that provides controlled and relatively constant inhalation of oxygen concentration (21%~100%), temperature (31 34 37℃) and  flow (10~90L/min) through a High Flow Nasal  Cannula.

High flow respiratory humidification treatment apparatus mainly includes air oxygen mixing device, humidification treatment apparatus, high flow nasal cannula and heating breathing pipeline.

Applicable Department

All kinds of intensive care unit (ICU), emergency department, respiratory department, infection department, neurosurgery, cardiothoracic surgery, otolaryngology, anesthesiology, pediatrics, geriatrics, hyperbaric oxygen department, rehabilitation department, etc.

Clinical Application

According to the Expert Consensus on Clinical Specifications and Application of Transnasal High Flow Humidification Oxygen Therapy for Adults issued by the Respiratory Society of Chinese Medical Association Chinese Journal of Tuberculosis and Respiratory Diseases, Vol. 42, No. 2, February 2019

Acute Type I Respiratory Failure

  •  Severe viral pneumonia, such as COVID-19 and H1N1, combined with Type I Respiratory Failure100 mmHg <PaO2 / FiO2  < 300 mmHg

  • PaO2 / FiO2  > 150 mmHg in patients with mild to moderate ARDS

  • Acute Cardiogenic Respiratory Failure

  • Immunosuppressive  secondary to Acute TypeⅠRespiratory Failure 

  • Acute exacerbation of Interstitial Pulmonary Disease

  • Invasive Mechanical Ventilation to remove the machine

  • ICU patients in critical condition were successively removed from the machine or alternately used with non-invasive ventilator

  •       Patients were removed from Mechanical Ventilation after surgery

      Type II Respiratory Failure

  •       Conscious patients with Acute Hypoxemia and Hypercapnia may try it, or alternately use it with a noninvasive ventilator


  • Patients with stable COPD;55 mmHg < PaO2 ≤ 60 mmHg, accompanied by pulmonary hypertension, clinical manifestations of Pulmonary Heart Disease or Hematocrit >0.55);Try to use or alternate with a Non-Invasive Ventilator.

    Expansion function

     Auxiliary Endoscopy Treatment, auxiliary Atomization Inhalation Treatment


It is suitable for patients with spontaneous breathing and should not be used on life support.





Tags

0
Prev:HUMID-BH2021-05-08
Next:HUMID-BM2021-05-08

Recently Viewed:

Copyright © 2020 Shenyang Maisi Medical Technology Co., Ltd copyright

辽ICP备14003915号-1